Friday, October 30, 2026

KAIST Develops Advanced Quadrupedal Robot with Self-Adaptive Walking Skills for Outdoor Environments

KAIST's Professor Park Hae-won reveals a new control tech for quadrupedal robots, enabling versatile locomotion in diverse terrains.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

Unveiling History: How the U.S. Altered Kim Young-sam’s Speech for North Korea Relations

U.S. modifies South Korea's speech before Kim's visit to prevent opposition backlash on North Korea aid during tense political climate.

Future

How Celltrion’s Remsima SC is Revolutionizing IBD Treatment at UEG Week 2026

Celltrion showcases the competitiveness of its autoimmune treatment Remsima SC at Europe's largest gastroenterology conference.

Interview: Kim Kyo-heung Says South Korea Needs National Suicide Prevention Fund, Citing 240-to-1 Budget Gap With Traffic Safety

Democratic Party lawmaker Kim Kyo-heung is calling for a dedicated national suicide prevention fund, arguing that per-death spending on suicide prevention is just one-240th of traffic safety spending and urging coordinated support for vulnerable young people, including those facing isolation, addiction and mental health crises.

“Focus on What We Do Well”: Kim Yeol-hong’s Vision for Yoo Han Corp.’s Next 100 Years

Yoo Han Corp. R&D chief Kim Yeol-hong says the company’s next century should be built around repeatedly developing new drugs by deepening expertise in selected fields, adopting new technologies and attracting global talent.

Yoo Han Corp. R&D Chief Kim Yeol-hong: “We Expect a Second Lexraza This Year … and Will Expand Drug Development”

Yoo Han Corp. R&D chief Kim Yeol-hong said the company expects follow-up drug development results by year-end while continuing to build a broad pipeline through both internal research and external acquisitions.

Alteogen Strengthens Keytruda SC Exclusivity With European Composition Patent

Alteogen has secured a European composition patent for the subcutaneous formulation combining its ALT-B4 enzyme with Merck’s Keytruda, strengthening intellectual property protection for the product in Europe.
Latest

Yuhan Corp. Signs $874 Million API Supply Deal With Global Pharmaceutical Company

Yuhan Corp. has secured a long-term active pharmaceutical ingredient supply contract worth $874 million with a global pharmaceutical company, expanding its overseas export business.

JNP Medi’s Maven Converter Nominated for Prix Galien Korea 2026: A Game-Changer in Clinical Trials?

JNP Medi's Maven Converter has been nominated for the Prix Galien Korea 2026, the first global pharma and biotech awards in Korea.

How Kangstem Biotech’s Organoid Technology is Revolutionizing Skin Disease Treatment with Global Pharma Partnerships

Kangstem Biotech accelerates global expansion by signing a drug evaluation contract with a major pharmaceutical company for skin immune diseases.

HLB Group’s New Cancer Drug Lirapegrafinib: What to Expect from FDA Approval on September 25?

HLB Group's drug development business is set to achieve key clinical and approval milestones in the second half of this year.

SK Biopharmaceuticals Introduces Opacalim: Aiming for a 2029 U.S. Launch of an Innovative Epilepsy Treatment

Opacalim licensing marks not an end, but a new beginning for opportunities and growth in the industry.

How K-Ramen Brands Are Boosting Global Sales with Samsung and LG Talent

South Korean ramen companies are hiring talent from Samsung and LG to boost global operations amid rising demand for K-Ramen.

Discover the New Galaxy Quantum7: SK Telecom’s Sleek and Powerful Smartphone

SK Telecom launches the Galaxy Quantum 7, a slim, high-performance device exclusive to its network.

Hanwha Aerospace Launches Hanwha Horizon USA: A Game Changer in Global LNG Supply Chains

Hanwha Aerospace establishes Hanwha Horizon USA to expand into the global liquefied natural gas (LNG) market.

Experience the Future: LA’s AI Art Museum and Autonomous Vehicles Transform Travel by 2027

Los Angeles showcases the future of travel with AI museums, self-driving cars, and immersive venues transforming the city.

Panasonic’s LEO Satellite Wi-Fi: How Parata Airlines is Transforming In-Flight Connectivity in 2026

Parata Airlines has signed a contract with Panasonic Avionics to introduce in-flight high-speed Wi-Fi on long-haul routes next year.

How the New BINSA Law Will Transform K-Bio: Opportunities and Challenges for Korean Companies

U.S. Congress is pushing for investment regulations targeting China's biotech industry, impacting global supply chains and local firms.

Why Son Heung-min is Starting on the Bench: Shocking Changes for LA FC vs. Colorado Rapids

Son Heung-min of LA FC will start on the bench for the first time in 14 matches in Major League Soccer.

Samsung Cements Design Excellence: 2 Awards for Ramian Landscaping at IDEA 2026

Samsung C&T's Raemian Landscaping wins two awards at the IDEA 2026, marking three consecutive years of recognition.

How PARKIE and STAN Are Transforming Parking and Logistics in Asia: A Comprehensive Guide

HL Robotics is launching autonomous parking robots PARKIE and STAN to enhance parking and logistics automation services.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.